| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 8,210.01 | 7,550.24 | 1,308.61 | 2,008.81 |
| Cash Equivalents | 61.89 | 45.17 | 53.86 | 74.85 |
| Other Liabilities Total | 19.41 | 18.35 | 2.40 | 2.15 |
| Accrued Expenses | 12.87 | 32.13 | 24.30 | 12.40 |
| Long Term Debt | 563.70 | 219.33 | 271.59 | 334.88 |
| Common Stock Total | 11.46 | 11.44 | 4.01 | 4.01 |
| Other Current Assets Total | 177.27 | 99.37 | - | - |
| Total Assets | 8,210.01 | 7,550.24 | 1,308.61 | 2,008.81 |
| Current Portof LT Debt/ Capital Leases | 721.44 | 123.90 | 156.73 | 314.33 |
| Cash | 35.68 | 156.48 | 6.47 | 4.97 |
| Total Equity | 5,831.29 | 5,880.58 | 395.71 | 785.45 |
| Long Term Investments | 10.22 | 6.91 | 3.79 | 0.00 |
| Retained Earnings( Accumulated Deficit) | 5,819.83 | -1,831.15 | -1,812.26 | -1,422.52 |
| Total Common Shares Outstanding | 11.46 | 11.44 | 11.44 | 11.44 |
| Tangible Book Valueper Share Common Eq | 45.75 | 43.90 | 6.14 | 39.13 |
| Goodwill Net | 3,827.53 | 3,827.53 | - | - |
| Total Liabilities | 2,378.73 | 1,669.66 | 912.90 | 1,223.36 |
| Total Debt | 1,503.94 | 942.44 | 571.17 | 864.22 |
| Short Term Investments | 21.92 | 8.88 | 15.79 | 4.50 |
| Cashand Short Term Investments | 119.49 | 210.53 | 76.12 | 84.33 |
| Total Receivables Net | 690.22 | 556.35 | 74.41 | 6.53 |
| Deferred Income Tax | 134.85 | 155.22 | - | - |
| Accounts Receivable- Trade Net | 690.22 | 422.78 | 55.24 | 3.82 |
| Property/ Plant/ Equipment Total- Net | 1,239.75 | 957.73 | 725.17 | 1,358.09 |
| Total Current Liabilities | 1,441.97 | 1,113.56 | 630.59 | 865.21 |
| Total Inventory | 438.96 | 207.18 | 22.74 | 136.47 |
| Accounts Payable | 374.55 | 175.51 | 81.02 | 94.82 |
| Other Currentliabilities Total | 333.10 | 346.01 | 234.01 | 249.77 |
| Total Long Term Debt | 782.50 | 382.53 | 279.91 | 355.99 |
| Intangibles Net | 1,479.42 | 1,550.67 | 325.45 | 337.71 |
| Other Long Term Assets Total | 227.16 | 18.31 | 4.91 | 12.45 |
| Note Receivable- Long Term | 0.00 | 102.92 | 72.92 | 72.16 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,425.94 | 1,086.18 | 176.38 | 228.40 |
| Capital Lease Obligations | 218.79 | 163.19 | 8.32 | 21.12 |
| Accumulated Depreciation Total | - | -356.29 | -423.73 | -311.57 |
| Other Equity Total | - | 2.06 | - | - |
| Prepaid Expenses | - | 12.76 | 3.11 | 1.08 |
| Additional Paid- In Capital | - | 7,698.23 | 2,203.96 | 2,203.96 |
| Property/ Plant/ Equipment Total- Gross | - | 1,253.64 | 1,148.89 | 1,669.66 |
| Notes Payable/ Short Term Debt | - | 436.01 | 134.53 | 193.90 |
Onesource Specialty Pharma Dividend Onesource Specialty Pharma Bonus Onesource Specialty Pharma News Onesource Specialty Pharma AGM Onesource Specialty Pharma Rights Onesource Specialty Pharma Splits Onesource Specialty Pharma Board Meetings Onesource Specialty Pharma Key Metrics Onesource Specialty Pharma Shareholdings Onesource Specialty Pharma Profit Loss Onesource Specialty Pharma Cashflow Onesource Specialty Pharma Q1 Results Onesource Specialty Pharma Q2 Results Onesource Specialty Pharma Q3 Results Onesource Specialty Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.